J. Zev Shainhouse
Corporate Officer/Principal chez Royal College of Physicians & Surgeons of Canada
Profil
Dr. Shainhouse heads Nuvo's research and development program, in addition to maintaining a staff position in the Internal Medicine/Infectious Disease Department of Scarborough General Hospital.
A graduate of the University of Toronto, Dr. Shainhouse is a member of the Royal College of Physicians and Surgeons of Canada, the Canadian Infectious Disease Society, and the Canadian Community and Hospital Infection Control Association.
Postes actifs de J. Zev Shainhouse
| Sociétés | Poste | Début |
|---|---|---|
Royal College of Physicians & Surgeons of Canada
 Royal College of Physicians & Surgeons of Canada Other Consumer ServicesConsumer Services The Royal College of Physicians & Surgeons of Canada operates a college for medical professionals. The non-profit company is based in Ottawa, Canada. The CEO of the Canadian company is Andrew Padmos. | Corporate Officer/Principal | - |
| Community & Hospital Infection Control Association | Corporate Officer/Principal | - |
Anciens postes connus de J. Zev Shainhouse
| Sociétés | Poste | Fin |
|---|---|---|
| NUVO PHARMACEUTICALS INC. | Directeur Technique/Scientifique/R&D | - |
Formation de J. Zev Shainhouse
| University of Toronto | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
Royal College of Physicians & Surgeons of Canada
Royal College of Physicians & Surgeons of Canada Other Consumer ServicesConsumer Services The Royal College of Physicians & Surgeons of Canada operates a college for medical professionals. The non-profit company is based in Ottawa, Canada. The CEO of the Canadian company is Andrew Padmos. | Consumer Services |
| Community & Hospital Infection Control Association |